Zdravlje | A Frontier Biopharma Company

For over 70 years, Frontier Zdravlje has been committed to one goal: empowering better health outcomes through quality, innovation, and trust. Every product we create and every partnership we build is focused on shaping a healthier future. At Frontier Zdravlje, we collaborate with you to bring your ideas to life. With our expertise, agility, and dedication, we help you navigate the pharmaceutical landscape, creating solutions that set new industry standards and accelerate progress. Since April 1st, 2021, Zdravlje has continued its journey as an independent pharmaceutical company under the ownership of Frontier Pharma and Baystone Group, UK-based pharmaceutical investors and entrepreneurs with extensive industry experience. Located in Leskovac, Serbia, Frontier Zdravlje operates EU-GMP approved manufacturing facilities that serve approximately 40 countries globally. With over 350 employees and an annual output of 1.7 billion units, we are a trusted partner in key markets, including the EU, UK, North America, Latin America, Asia Pacific, and Africa.